PPB Pharmacist Pre-registration Exam study plan
PPB Pharmacist Pre-registration Exam · Give each week a clear focus.
8 weeks · About 7 hours per week
Registration and Marketing Authorisation (MA)
Map the full MA lifecycle from pre-submission to post-authorisation variation, listing each regulatory step and its required documentation in your own notes
Distinguish national, decentralised, mutual recognition and centralised procedures, and state which application type fits three given product scenarios
Classify five example product changes as Type IA, Type IB or Type II variations and justify each classification
Explain the structure and purpose of the Common Technical Document modules and identify which module holds quality, safety and efficacy data
Draft a one-page checklist of the dossier sections a candidate would expect to see in a new marketing authorisation application
Your checkpoint
A two-page MA procedure comparison table plus a variation classification log covering at least ten worked examples
Registration and Marketing Authorisation (MA) & Quality Control (Lab and Lot Release)
Link MA dossier quality requirements to the pharmacopoeial and specification controls that support them
Describe how active substance and finished product specifications are set, including acceptance criteria and justification
Explain validation of analytical methods by listing the parameters assessed and when revalidation is triggered
Outline the lot release pathway for a biological product and identify which tests require independent laboratory confirmation
Compare in-house, contract and official control laboratory roles in release testing
Your checkpoint
A one-page flowchart connecting dossier quality data through specification setting to lot release, with a short written rationale for each decision point
Quality Control (Lab and Lot Release) & Regulatory Inspections
Interpret out-of-specification and out-of-trend results and describe the investigation sequence expected before a batch decision
Explain stability study design, including bracketing and matrixing, and state what shelf-life claims they support
Prepare for an inspection by listing the documentation an inspector would request in a quality control laboratory
Describe how inspection findings are graded, from critical to minor, and outline a corrective and preventive action plan for one critical finding
Identify the difference between routine, for-cause and pre-approval inspections and what triggers each
Your checkpoint
A simulated OOS investigation report with root cause, CAPA and batch disposition decision, plus an inspection readiness checklist of at least fifteen items
Regulatory Inspections & Licensing, Good Pharmacy Practice, Training & Continuing Professional Development (CPD)
Map the licensing requirements for a pharmacy premises, including the responsible pharmacist role and conditions attached to a licence
Explain good pharmacy practice standards for dispensing, storage, cold chain and record keeping, and self-audit against them
Build a personal CPD cycle, recording a learning need, planned activity, reflection and outcome for one real activity
Describe how training records and competence assessments are evidenced during an inspection
State the actions a responsible pharmacist must take when a licence condition is breached or a serious incident occurs
Your checkpoint
A completed CPD record for one activity plus a premises self-audit scored against at least ten good pharmacy practice standards
Clinical Trials
Outline the clinical trial authorisation route, listing the submissions and approvals needed before first participant in
Explain the roles and legal responsibilities of sponsor, investigator, monitor and ethics committee across a trial
Apply informed consent requirements to two scenarios, including a vulnerable participant, and state what makes consent valid
Describe good clinical practice requirements for source data, case report forms and investigational product accountability
Classify three safety events as adverse event, serious adverse event or suspected unexpected serious adverse reaction and state the reporting timelines
Your checkpoint
A trial site file index with a written justification for each essential document, plus three worked safety reporting cases with timelines
Vigilance (Pharmacovigilance)
Describe the pharmacovigilance system and its quality requirements, including the role of the qualified person responsible for pharmacovigilance
Distinguish individual case safety reports from periodic safety reports and state the reporting timelines and routes for each
Explain signal detection and how a signal is validated, prioritised and followed by regulatory action
Describe risk management plans and risk minimisation measures, giving one example of routine and one of additional measures
Trace the actions following a serious safety concern, from assessment through variation, suspension or withdrawal
Your checkpoint
A one-page signal management workflow with a worked case showing detection, assessment, regulatory action and communication
Market Surveillance and Control & Online Systems
Explain market surveillance activities, including sampling and testing programmes, and how non-compliant products are handled
Describe the recall classification system and outline the steps and timelines for a recall from notification to effectiveness check
Identify the falsified medicine risks and the checks used to verify a suspicious product
Navigate the online regulatory systems used for applications, submissions and safety reporting, and list the data fields each requires
Explain how electronic systems support traceability, including batch and product identification, and what a data integrity failure would look like
Your checkpoint
A mock recall plan with classification, notification steps and effectiveness check, plus a table of online system functions mapped to the regulatory tasks they support
Registration and Marketing Authorisation (MA) & Licensing, Good Pharmacy Practice, Training & Continuing Professional Development (CPD) & Regulatory Inspections & Clinical Trials & Market Surveillance and Control & Vigilance (Pharmacovigilance) & Quality Control (Lab and Lot Release) & Online Systems
Synthesise all domains by writing short answers to two integrated scenarios that each span at least three domains
Revisit your weakest two domains using your own notes and correct any factual errors found
Complete a timed mixed-domain practice set and review every incorrect answer to its source rule
Consolidate a one-page summary sheet of key timelines, thresholds and reporting routes for final revision
Confirm exam-day logistics and rehearse the summary sheet from memory
Your checkpoint
A completed timed mixed practice set with a written error log, plus a final one-page timeline and threshold summary sheet
Milestones
Week 2: You can explain the MA procedure options and variation classes without notes and have finished the procedure comparison table
Week 4: You have completed the CPD record and premises self-audit, and can describe the inspection grading scheme and CAPA process
Week 6: You can state safety reporting timelines and routes from memory and have completed the signal management worked case
Week 8: You have scored your timed mixed practice set, logged every error with its cause, and can reproduce the timeline and threshold summary sheet from memory